The ideal joint replacement for CMC thumb arthritis.

ZEPART^TM is an advanced, anatomically optimized thumb implant for effective CMC osteoarthritis treatment.

Unique Joint Replacement

Our proprietary thumb CMC implant addresses a compelling opportunity in joint reconstruction with a distinctly differentiated design optimized for stability, strength and flexibility. Conceived by leading U.S. hand surgeon Nathan T. Morrell, MD, and advanced in partnership with a multidisciplinary science and engineering team, the platform reflects the integration of AI-enabled design, rigorous validation, and clinical insight to support meaningful performance and long-term commercial value.

ZEPART^TM Thumb Implant

Without a suitable joint replacement technology, surgeons are reduced to compromising treatment options for painful thumb CMC joint damaged by osteoarthritis. Our revolutionary implant meets the surgeon’s need for a stable, functional, adaptable thumb CMC joint replacement. Implementation of the ZEPART implant has the potential to address pain management for the millions of patients with this condition and restore quality of life.

LEARN MORE

The implant shown has not yet received FDA clearance, nor CE marking. It is not available for sale in the United States nor in Europe.

ZEPART® Thumb Implant

Without a suitable joint replacement technology, surgeons are reduced to compromising treatment options for painful thumb CMC joint damaged by osteoarthritis. Our revolutionary implant meets the surgeon’s need for a stable, functional, adaptable thumb CMC joint replacement. Implementation of the ZEPART implant has the potential to address pain management for 200,000+ patients with this condition and restore quality of life.

LEARN MORE

The device shown is currently under development and has not yet received FDA clearance or approval. It is not available for sale in the United States.